A study to evaluate the safety and efficacy
of Xyrem® for the treatment of Fibromyalgia
syndrome.
Male or female patients over 18 years who
have been diagnosed with fibromyalgia to
participate in a trial lasting up to 27 weeks
with 12 visits. Treatment period is 14 weeks.
Patients who complete this study may be
eligible to enter long-term (9 1/2 months)
open-label extension study. [...]
Tuesday, June 10, 2008
Subscribe to:
Post Comments (Atom)
1 comment:
very informative site..ty for dropping by...
Post a Comment